Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 9:39 PM
Ignite Modification Date:
2025-12-25 @ 7:21 PM
NCT ID:
NCT01833832
Group ID:
EG000
Title:
Cytoreductive Surgery Followed by HIPEC
Description:
Cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy (HIPEC) with cisplatin
Cisplatin: Patients who are successfully debulked will then undergo hyperthermic intraperitoneal chemotherapy (HIPEC) with cisplatin.
Cytoreductive surgery: Patients will undergo cytoreductive surgery to achieve a Completeness of Cytoreduction Score (CC) of 0 or 1.
sodium thiosulfate: sodium thiosulfate will be given to limit the toxicity of cisplatin
Deaths Number Affected:
3
Deaths Number At Risk:
None
Serious Number Affected:
1
Serious Number At Risk:
11
Other Number Affected:
8
Other Number At Risk:
11
Study:
NCT01833832
Results Section:
NCT01833832
Adverse Events Module:
NCT01833832